Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Deep mutational scanning reveals the pathogenicity and structural constraints of a comprehensive set of rhodopsin missense variants
Author Affiliations & Notes
  • Kannan Vrindavan Manian
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Erin Hennessey
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ha Eun
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Hilary Scott
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Xiaoping Yang
    Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Boston, Massachusetts, United States
  • David E Root
    Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Boston, Massachusetts, United States
  • Eric A Pierce
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Jason Comander
    Ocular Genomics Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Kannan Manian None; Erin Hennessey None; Ha Eun None; Hilary Scott None; Xiaoping Yang None; David Root Functional Genomics Consortium (Abbvie, BMS, Jannsen, Merck, Vir), Code F (Financial Support), Director of Addgene, Inc, Code F (Financial Support); Eric Pierce None; Jason Comander Octant, Code C (Consultant/Contractor)
  • Footnotes
    Support  NEI R01 EY031036 (JC) and P30EY014104 (MEEI core support). Foundation Fighting Blindness ECDA.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 457. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kannan Vrindavan Manian, Erin Hennessey, Ha Eun, Hilary Scott, Xiaoping Yang, David E Root, Eric A Pierce, Jason Comander; Deep mutational scanning reveals the pathogenicity and structural constraints of a comprehensive set of rhodopsin missense variants. Invest. Ophthalmol. Vis. Sci. 2024;65(7):457.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In human genetic testing results for inherited retinal diseases such as retinitis pigmentosa (RP), the presence of variants of unknown significance (VUS) can be a major barrier to establishing a firm genetic diagnosis. VUS can even affect access to precision medicine clinical trials. Mutations in rhodopsin are the most common cause of dominant RP. The purpose of this work is to identify every potential RHO missense variant with a pathogenic surface expression level using deep mutational scanning and a high-throughput cell-based assay, with the goals of reclassifying a large number of VUS and obtaining structural insights into the rhodopsin protein.

Methods : A cDNA library with every possible RHO missense variant (N=7299) was designed, synthesized, cloned, produced in lentivirus, and transduced into HEK293T cells by spinfection at a low MOI, and selected by puromycin. Surface antibody staining and FACS was used to sort stained cells into low- and high-RHO-expressing populations. gDNA from each population was uncrosslinked, extracted, PCR amplified, and quantified using NGS deep sequencing of the cDNA region of the integrand. A second experiment assayed how expressed variants underwent selection during 25 days of passaging in terms of gain-of-function toxicity. ASM 1.0 software was used to derive a surface expression or fitness map of all amino acid variants present in the RHO library.

Results : Variant coverage in the final data was >99% of all missense variants. While <150 pathogenic or likely pathogenic missense mutations in RHO were previously known across all studies (ClinVar), this study identified hundreds of new missense mutations with pathogenic expression levels. Structural insights based on the variant heatmap included identification of a low constraint region at the C-terminus and in cytoplasmic loop 3, and mapped the extent of the constrained beta-plug region in extracellular loop 2. Tolerance of specific amino acid changes varied depending on their location within the structure (e.g. within transmembrane domains).

Conclusions : A simple surface protein expression assay, when multiplexed over nearly all potential RHO missense mutations, was able to greatly expand knowledge of medically-important RHO missense variants, as well as provide detailed structural insights into this archetypal G-protein coupled receptor.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×